Covid-19 Vaccine
| Question | Evidence-Based, Logic-Driven Response (COVID-19) |
|---|---|
| What is my child’s actual risk of dying from this disease, statistically? | Based on CDC, UK, and German health agency data from 2020–2023: - In healthy children ages 0–17, the infection fatality rate (IFR) is 0.0003% or lower. - For children under 5: virtually zero deaths without serious preexisting illness. - Most pediatric deaths involved multiple comorbidities, prematurity, or immune deficiency. |
| Have you lost an unvaccinated patient to COVID? Any patients lost to the vaccine? | Almost no pediatrician has lost a healthy child to COVID. However, deaths post-COVID vaccine in children have been reported in VAERS and international databases, including myocarditis, arrhythmia, and sudden cardiac arrest. |
| Odds of any side effect? Severe side effect? Compared to risk of death from virus? | - Common: headache, fatigue, fever, myocarditis (esp. males 12–24). - Pfizer’s own data showed more adverse events than infection-related complications in 5–11 age group. - Moderna trial data showed high rates of Grade 3 adverse events (preventing normal activity). - Myocarditis risk in 12–17 males is higher post-vaccine than post-infection, per FDA and Israeli data. |
| Most severe adverse event you've seen? Most common? | - Common: fatigue, fever, arm pain. - Severe: myocarditis, pericarditis, seizures, stroke, death (documented in VAERS, V-safe, and Yellow Card systems). - Thousands of reports of post-vaccine cardiac arrest, especially in adolescent males, globally. |
| Worst-case outcome from insert or VAERS? How many deaths? | - VAERS (as of 2024): Over 2,000 death reports in individuals under 30, dozens in under-18s. - Many occurred within 48 hours post-injection. - Myocarditis listed as a risk by FDA, EMA, WHO. - Package insert (Pfizer) lists: anaphylaxis, myocarditis, Bell’s palsy, thrombocytopenia, death. |
| Recent VAERS reports? Severity? | Recent reports (2023–2024): sudden death, myocarditis, convulsions, menstrual abnormalities, multi-system inflammation, and neurological decline post-mRNA injection. CDC’s own “V-safe” app showed 1 in 3 kids missing school or needing care after dose 2. |
| How many VAERS reports have you filed? Do you follow up? | Most pediatricians file none. V-safe and VAERS were overwhelmed in 2021–2022, but most doctors were unaware or told adverse events were “normal.” No structured follow-up occurs. |
| Will antibody levels or T-cell immunity be tested before giving more doses? Why one-size-fits-all? | No testing is done. All children are treated as needing the same number of doses regardless of prior infection or natural immunity — despite data showing prior infection confers equal or better protection with fewer risks. |
| Can you guarantee this vaccine won’t cause autoimmune, neurological, reproductive, or cardiovascular damage? | No. Pfizer and Moderna skipped long-term safety trials. Autoimmunity, neurological injury, and fertility impacts are biologically plausible and under investigation. - Spike protein and LNPs cross the blood-brain and placental barriers. |
| Was it tested against a saline placebo? What were the outcomes? | Initial trials had placebo groups, but unblinded early — meaning true long-term placebo-controlled data does not exist. Also: original trials excluded high-risk children and had short follow-ups (2 months max). |
| Do you have unvaccinated patients? Have you ever advised against the COVID shot for a child? | Most doctors followed ACIP guidance. Few recommended against it, even for children with prior infection, mitochondrial conditions, seizure disorders, or autoimmune risk. |
| If a child reacts severely, do you stop subsequent doses? | Most doctors still encouraged second doses or boosters even after ER visits or cardiac symptoms, unless myocarditis was confirmed and hospitalized. |
| Can we walk through the insert and ingredients? | - Pfizer: lipid nanoparticles (ALC-0315), polyethylene glycol (PEG), mRNA encoding spike protein. - Moderna: similar formulation with higher mRNA content. - Risks: myocarditis, pericarditis, thrombosis, Guillain-Barré, Bell’s palsy, death. |
| How do you determine causation in adverse events? | Most events post-injection are labeled “coincidental.” But data show clear temporal clusters, especially for myocarditis (2–5 days post-shot). - FDA and CDC admit these patterns but continue recommending the shot. |
| Are there long-term outcome studies comparing vaccinated vs. unvaccinated children? | No. There are no long-term studies of mRNA vaccine effects in children. No fertility, neurodevelopment, cancer risk, or autoimmune follow-up exists beyond a few months. |
| Are you concerned about how rapidly this was added to the childhood schedule? | Added to the CDC schedule in 2023, despite declining disease severity, widespread natural immunity, and rising concerns about cardiac events. - Never tested for long-term safety in children. - No liability — manufacturers shielded under PREP Act. |
| Have you noticed a rise in chronic issues in children post-2021? | Pediatricians are increasingly reporting: - Menstrual disruption, myocarditis, arrhythmia, autoimmune flares, anxiety, cognitive delays, and PANS-like syndromes post-mRNA vaccines. Most are dismissed or downplayed. |
| If my child had a severe reaction, would you acknowledge it publicly? | Most would not. CDC and FDA guidelines discourage open acknowledgment. Whistleblowers (e.g., Dr. Retsef Levi at MIT) have faced suppression for publishing safety concerns. |
| Are you under institutional or insurance pressure to push the shot? | Yes. COVID vaccine uptake has been tied to funding, school entry, and practice metrics. Hospitals and systems often mandated staff compliance, reinforcing top-down pressure. |
| Do you know how the Vaccine Injury Compensation Program works for COVID vaccines? | No. COVID shots are not covered by the standard VICP. They fall under the Countermeasures Injury Compensation Program (CICP) — a system that: - Has paid out less than 5 claims by 2024. - Offers no court access, no appeals, no independent review. - Burden of proof is extreme. Most families receive nothing, even with hospitalization or death. |